Ποια είναι η τιμή για General Biologicals Corporation (4117)

Η τιμή για General Biologicals Corporation (4117) είναι $0.31640033

Ποια είναι η κεφαλαιοποίηση αγοράς για General Biologicals Corporation (4117)

Η κεφαλαιοποίηση αγοράς για General Biologicals Corporation (4117) είναι $22.25M

General Biologicals Corporation (4117) Δείκτης P/B

General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.

Έτος	Δείκτης P/B	Αλλαγή
Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Έτος

Δείκτης P/B

Αλλαγή

Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.

Εταιρεία	Δείκτης P/B	Διαφορά Δείκτη P/B	Χώρα
STERIS plc STE.US	3.1593	-	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	-	-	CN
Ypsomed Holding AG YPSN.SW	-	-	CH
Medacta Group S.A. MOVE.SW	-	-	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	-	-	CN

Εταιρεία

Δείκτης P/B

Διαφορά Δείκτη P/B

Χώρα